Abbott announced on 7 March it received US Food and Drug Administration clearance for a laboratory-based blood test used in hospitals to help clinicians assess mild traumatic brain injuries (TBI) in about 18 minutes.
A negative result rules out the need for a computed tomography (CT) scan and potentially long wait times in the...






